With the analysis among 2,635 patents, we discovered top 466 key players by total patent application. Toray Industries, Inc., AstraZeneca Pharmaceutical Co., Ltd., Grünenthal GmbH are dominant in this area. They take 8.54% of the total patent filing.
Tokyo-to, Japan
Patent: 97
AstraZeneca Pharmaceutical Co., Ltd.
Jiangsu Sheng, China
Patent: 74
Nordrhein-Westfalen, Germany
Patent: 54
Luxembourg, Luxembourg
Patent: 46
Tokyo-to, Japan
Patent: 43
Nippon Zoki Pharmaceutical Co. Ltd.
Osaka-fu, Japan
Patent: 36
Gyeonggi-do, South Korea
Patent: 27
Tokyo-to, Japan
Patent: 26
Budapest, Hungary
Patent: 26
With the analysis among 13 patents, we discovered top 5 start-ups by total patent application. Institut National de la Santé et de la Recherche Médicale, Biodol Therapeutics SAS, Beijing Xinyun Medical Technology Co. Ltd. are active in this area.
Institut National de la Santé et de la Recherche Médicale
Beijing Xinyun Medical Technology Co. Ltd.
Beijing Shi, China
Patent: 2
Telangana, India
Patent: 1
With the analysis among related 734 patents applied in the last 5 years. We discover 335 most active companies in this area. The fast-growing Shenzhen Ruijian Biotechnology Co., Ltd., Fruithy Holdings Limited, Sichuan Haisco Pharmaceutical Co., Ltd. take 5.31% of patent filing during this period.
Shenzhen Ruijian Biotechnology Co., Ltd.
Guangdong Sheng, China
Patent: 17
undefined undefined
Patent: 12
Sichuan Haisco Pharmaceutical Co., Ltd.
Sichuan Sheng, China
Patent: 10
West China Hospital of Sichuan University
Taiwan Liposome Co., Ltd.
Taiwan Province, China
Patent: 9
Chinese Academy of Medical Scciences & Peking Union Medical College
Shanghai Institute of Materia Medica Chinese Academy of Sciences
Shanghai Shi, China
Patent: 8
TLC Biopharmaceuticals, Inc.
California, United States
Patent: 8
Huzhou Enovix Pharmaceutical Co., Ltd.
Zhejiang Sheng, China
Patent: 6
Boston Scientific Neuromodulation Corp.
California, United States
Patent: 6
With the analysis among related 734 patents in last 5 years, we discover 262 new entrants. Shenzhen Ruijian Biotechnology Co., Ltd., Fruithy Holdings Limited, Taiwan Liposome Co., Ltd. are the most active new entrants in this area.
Shenzhen Ruijian Biotechnology Co., Ltd.
Guangdong Sheng, China
Patent: 17
undefined undefined
Patent: 12
Taiwan Liposome Co., Ltd.
Taiwan Province, China
Patent: 9
Shanghai Institute of Materia Medica Chinese Academy of Sciences
Shanghai Shi, China
Patent: 8
TLC Biopharmaceuticals, Inc.
California, United States
Patent: 8
Huzhou Enovix Pharmaceutical Co., Ltd.
Zhejiang Sheng, China
Patent: 6
Boston Scientific Neuromodulation Corp.
California, United States
Patent: 6
Institut National de la Santé et de la Recherche Médicale
With the analysis among 661 patents, we discovered top 171 universities and scientific research institutions by total patent application. Virginia Commonwealth University, China Pharmaceutical University, Chengdu University of Traditional Chinese Medicine are dominant in this area. They take 6.81% of the total patent filing.
Virginia Commonwealth University
Virginia, United States
Patent: 13
China Pharmaceutical University
Jiangsu Sheng, China
Patent: 12
Chengdu University of Traditional Chinese Medicine
Sichuan Sheng, China
Patent: 12
Chinese Academy of Medical Scciences & Peking Union Medical College
Guangdong Sheng, China
Patent: 9
Shenyang Pharmaceutical University
Liaoning Sheng, China
Patent: 9
Beijing Shi, China
Patent: 8
Nanjing University of Chinese Medicine
Jiangsu Sheng, China
Patent: 8
Shanghai Institute of Materia Medica Chinese Academy of Sciences
Shanghai Shi, China
Patent: 8